ETHK Labs Inc.
关于公司 About
ETHK Labs Inc. (01931.HK) is a world-leading AI healthcare capital operation platform. With over 30 years of experience in IVD distribution, its subsidiary, Vastec, serves as the exclusive distributor of Sysmex’s coagulation products in China, holding the top market share in the country’s primary coagulation IVD distribution market. Currently, the company focuses on AI-driven healthcare capital operations, with an ecosystem of over 5,000 employees. Through mergers and acquisitions, ETHK Labs aims to advance access to high-quality healthcare, address urgent human challenges such as disease, aging, and healthcare inequality, and ultimately enable billions of people to “live better.” The company's sole approach is mergers and acquisitions (M&A), through which it integrates global AI healthcare segment leaders. Leveraging its three proprietary growth curves and the synergistic collaboration among ecosystem members, ETHK Labs enhances and amplifies the value of its acquisition targets, accelerates the transformation of cutting-edge innovations into scalable commercial returns and exponential capital premiums, and reshapes the value distribution landscape of the global healthcare industry.